Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from___ to___ Commission file number: 333-257810 MaxCyte, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdi ...

MaxCyte, Inc. (NASDAQ:MXCT) Q2 2021 Earnings Conference Call September 13, 2021 4:30 PM ET Company Participants Sean Menarguez - IR Doug Doerfler - CEO Amanda Murphy - CFO Conference Call Participants Julie Simmonds - Panmure Gordon Max Masucci - Cowen & Co. Dan Arias - Stifel Matt Larew - William Blair Mark Massaro - BTIG Jacob Johnson - Stephens, Inc. Sean Menarguez Good afternoon, everyone. Thank you all for participating in today's conference call. On the call for MaxCyte, we have Doug Doerfler, Chief E ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from___ to___ Commission file number: 333-257810 MaxCyte, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction ...